glp 1 latest GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 How GLP-1 medications are transforming

The most common are gastrointestinal issues, including nausea, which typically occurs during dose escalation, vomiting in some patients, diarrhea or constipation, and abdominal discomfort

The metabolic pathway mapping indicated that these significantly changed metabolites were associated with cysteine and methionine metabolism, ferroptosis, and biosynthesis of unsaturated fatty acids pathways

Discussion PCOS, a highly prevalent and incurable disease affecting female reproductive, endocrine, metabolic, and mental health, demands the urgent exploration of more effective, safer, and cost-effective drugs or therapies to improve symptoms and enhance fertility

Is berberine as good as Ozempic